Group by: Creators | Item Type | Date
Jump to: Article | Monograph
Number of items at this level: 7.

Article

Berndt, Ernst R.IdRef and Dubois, PierreIdRef (2016) Impacts of Patent Expiry of Pharmaceutical Treatments in Eight OECD Countries, 2004-2010. International Journal of the Economics of Business, vol. 23 (n° 2). pp. 125-147.

Dubois, PierreIdRef, Mouzon, Olivier deIdRef, Scott Morton, Fiona and Seabright, PaulIdRef (2015) Market Size and Pharmaceutical Innovation. RAND Journal of Economics, vol. 46 (n° 4). pp. 844-871.

Kyle, MargaretIdRef and McGahan, Anita M. (2012) Pharmaceutical Investments Before and After TRIPS. Review of Economics and Statistics, 94 (4). pp. 1157-1172.

Tunçel, TubaIdRef (2024) Should We Prevent Off-Label Drug Prescriptions? Empirical Evidence from France. The Review Of Economic Studies.

Monograph

Berndt, Ernst R.IdRef and Dubois, PierreIdRef (2012) Impacts of Patent Expiry and Regulatory Policies on Daily Cost of Pharmaceutical Treatments: OECD Countries, 2004-2010. TSE Working Paper, n. 12-283

Dubois, PierreIdRef, De Mouzon, OlivierIdRef, Scott Morton, Fiona and Seabright, PaulIdRef (2011) Market Size and Pharmaceutical Innovation. TSE Working Paper, n. 11-232

Dubois, PierreIdRef, Majewska, GosiaIdRef and Reig, ValentinaIdRef (2023) Drug shortages: empirical evidence from France. TSE Working Paper, n. 23-1417, Toulouse

This list was generated on Fri Jan 16 04:47:23 2026 CET.